Literature DB >> 3877901

Cell mediated immunity to liver fluke antigens during experimental Fasciola hepatica infection of cattle.

G Oldham, L Williams.   

Abstract

Cell mediated immunity (CMI) to Fasciola hepatica antigens was detected by lymphocyte proliferation and interleukin-2 (IL-2) production tests in cattle during the first 4 weeks following liver fluke infection. From the fifth week of infection onwards peripheral blood lymphocytes were unresponsive to fluke antigens by these in vitro tests. Investigations into the cause of this unresponsiveness found no evidence to suggest a selective loss of the IL-2 producing lymphocyte sub-population or that macrophages were responsible for the suppression or that antigen responsive cells were being sequestered in the spleen and mesenteric lymph nodes. Tests carried out on culture supernatants demonstrated the production during this unresponsive period of factors capable of suppressing in vitro responses to PHA. Although further tests failed to show antigen specific suppressor factors the presence of MHC restricted suppressor factors could not be ruled out. The early and transient appearance of CMI during F. hepatica infection of cattle indicates that delayed type hypersensitivity is unlikely to be important in protective immunity in cattle.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3877901     DOI: 10.1111/j.1365-3024.1985.tb00095.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  9 in total

1.  Comparison between in-house indirect ELISA and Dot-ELISA for the diagnosis of Fasciola gigantica in cattle.

Authors:  Jafar Arjmand Yamchi; Nasser Hajipour; Seyyed Meysam Abtahi Froushani; Mojtaba Keighobadi
Journal:  J Parasit Dis       Date:  2015-06-23

2.  Fasciola hepatica: identification of CD4+ T-helper epitopes from the 11.5 kDa saposin-like protein SAP-2 using synthetic peptides.

Authors:  Ana M Espino; Daricel Torres; Adelaida Morales; Bonnibel Delgado; Julia Quetel; Antonio Osuna
Journal:  Exp Parasitol       Date:  2007-03-27       Impact factor: 2.011

3.  CD4+ T-cell clones obtained from cattle chronically infected with Fasciola hepatica and specific for adult worm antigen express both unrestricted and Th2 cytokine profiles.

Authors:  W C Brown; W C Davis; D A Dobbelaere; A C Rice-Ficht
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441

4.  Proliferative responses and IL-2 production by mononuclear cells from bovine mammary secretions, and the effect of mammary secretions on peripheral blood lymphocytes.

Authors:  R A Collins; G Oldham
Journal:  Immunology       Date:  1986-08       Impact factor: 7.397

Review 5.  Evasion of Host Immunity During Fasciola hepatica Infection.

Authors:  Robin J Flynn; Mayowa Musah-Eroje
Journal:  Methods Mol Biol       Date:  2020

6.  Designing and evaluation of Dot-ELISA for diagnosis of Fasciola infection in cattle.

Authors:  Jafar Arjmand; Bijan Esmaeilnejad; Mohammad Hossein Razi Jalali; Masoud Ghorbanpoor; Seyyed Meysam Abtahi Froushani
Journal:  Vet Res Forum       Date:  2014       Impact factor: 1.054

7.  Fasciola hepatica reinfection potentiates a mixed Th1/Th2/Th17/Treg response and correlates with the clinical phenotypes of anemia.

Authors:  M Adela Valero; Ignacio Perez-Crespo; Carlos Chillón-Marinas; Messaoud Khoubbane; Carla Quesada; Marta Reguera-Gomez; Santiago Mas-Coma; Manuel Fresno; Núria Gironès
Journal:  PLoS One       Date:  2017-03-31       Impact factor: 3.240

8.  Characterization of the Pathology, Biochemistry, and Immune Response in Kunming (KM) Mice Following Fasciola gigantica Infection.

Authors:  Xuefang Mei; Yaoyao Zhang; Chenyu Quan; Yiying Liang; Weiyi Huang; Wei Shi
Journal:  Front Cell Infect Microbiol       Date:  2022-01-05       Impact factor: 5.293

9.  Dairy Heifers Naturally Exposed to Fasciola hepatica Develop a Type 2 Immune Response and Concomitant Suppression of Leukocyte Proliferation.

Authors:  John Graham-Brown; Catherine Hartley; Helen Clough; Aras Kadioglu; Matthew Baylis; Diana J L Williams
Journal:  Infect Immun       Date:  2017-12-19       Impact factor: 3.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.